The PE ratio for Resmed stock stands at 24.52 as of Sep 28, 2023. This is calculated based on the TTM EPS of $6.12 and the stock price of $150.05 per share. A decrease of 35% has been observed in the PE ratio compared to its average of 37.8 of the last four quarters.
Over the last ten years, the average PE ratio of Resmed has been 37.34. The current 24.52 P/E ratio is 34% lower than the historical average. Looking back at the last ten years, RMD's PE ratio peaked in the Sep 2021 quarter at 76.39, with a price of $263.55 and an EPS of $3.45. The Mar 2014 quarter marked the lowest point at 19.18, with a price of $44.69 and an EPS of $2.33.
Maximum annual increase: 69.23% in 2021
Maximum annual decrease: -47.92% in 2022
Currently, RMD's PE ratio is lower than its 3, 5 and 10-year averages.
RMD's PE ratio stands lower than its peer stocks TMO and MDT. Resmed's current PE ratio of 24.52 is lower than the average of its peers, which is 32.78.
|Stock name||PE ratio||Market cap|
|RMD Resmed Inc||24.28||$21.85B|
|ELMD Electromed Inc||27.84||$88.12M|
|MDT Medtronic plc||28.85||$104.41B|
|TMO Thermo Fisher Scientific Inc||34.45||$195.72B|
|MASI Masimo Corp||40.84||$4.75B|
|INGN Inogen Inc||N/A||$122.23M|
RMD's price to earnings ratio is 24.52 as of Sep 28, 2023.
As an average over the last 3 years, RMD stock has a PE ratio of 50.16.
As an average over the last 5 years, RMD stock has a PE ratio of 47.23.
Over the last ten years, the Sep 2021 quarter recorded the highest quarterly PE ratio at 76.39.
The current PE ratio of RMD is 34% lower than the 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Sep 28, 2023), Resmed's share price is $150.05. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2023 is $6.12. Therefore, Resmed's PE ratio for today is 24.52.
PE RATIO(24.52) = STOCK PRICE($150.05) / TTM EPS($6.12)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.